Pharma Marketing Network

Genentech's 4HER iPhone App for women with HER2 breast cancer is interesting and perhaps unique in a Mobile Health App developed by a pharma...

Join me tomorrow, October 9, 2014, 12 noon Eastern U.S., for an hour-long TweetChat on how pharma can develop high quality mobile health apps....

Here's something you don't see every day: a Sixty Minutes report that slams the extraordinarily high prices charged for cancer drugs -- e.g., $100,000...

I received several interesting comments to my post on LinkedIn regarding the pharma industry's reaction to FDA's recent "Guidance for Industry Internet/Social Media Platforms with...

Wowie zowie! Is that a roll of dimes quarters in my pocket or am I just excited to see this new Viagra DTC TV...

This article summarizes the comments from a LinkedIn debate and #mHealthPharma TweetChat and condenses the learnings into one simple formula for creating quality pharma mHealth apps.

This article summarizes the social media accomplishments -- despite bumps in along the way -- that earned the Boehringer Ingelheim (BI) Global Social Media Team the coveted Pharmaguy Social Media Pioneer Award.

This article summarized the industry's response to the second FDA social media guidance document regarding correcting and/or responding to misinformation related to a firm's own FDA-approved products when that information is created or disseminated by independent third parties on the Internet or through social media.

Welcome to Volume 13, Issue #9 (OCTOBER 2014) of Pharma Marketing News.

Dale Cooke (@PhillyCooke on Twitter) live tweeted from the FDLI's Advertising and Promotion Conference yesterday and asked the question: "Do # of violation letters (low)...